FDA aligned on single-arm Phase 3 study to support potential accelerated and full approval On track to dose first patient...
FDA aligned on single-arm Phase 3 study to support potential accelerated and full approval On track to dose first patient...
Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on Webull here...
Innovative targeted oncology company built on next-generation ADCs and a novel discovery engine Connect with the Company on Webull here...
LONDON, Feb. 3, 2025 /PRNewswire/ - MYndspan, a pioneer in consumer brain health technology, and BIOS Health, a leader in...
COPENHAGEN, Denmark, January 31, 2025 – Bavarian Nordic A/S (OMX: BAVA) announces that the share buy-back program, which was announced...
●Q4 and FY Test volume increase 21% and 17% year-over-year ●Q4 and FY Volume, Revenue, and Profitability at all-time record levels...
TORONTO, Jan. 30, 2025 /PRNewswire/ -- Kinectrics and Isotopia have announced a groundbreaking agreement under which Kinectrics will provide Isotopia...
Breakthroughs in veterinary medicine, immersive hands-on experiences and Academy Award-winning actor and director Kevin Costner headline the world's largest and...
SALT LAKE CITY, Jan. 30, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq-CM: CODX) (the "Company" or "Co-Dx"), a molecular diagnostics company...
Mom-led company introduces new products designed for effortless breast milk collection and storage after successful 2024 growth SAN FRANCISCO, Jan....
Brings total deployable capital raised to date to $125 million and will enable completion of first biomanufacturing plant in Richmond,...
The latest addition to the Navigator365™ Omnichannel product family transforms how life sciences companies engage with digital influencers through actionable insights...
Opening plenary session features latest fetal fraction amplification researchSALT LAKE CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc....
VANCOUVER, British Columbia, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSX-V: RKV), a biopharmaceutical company advancing innovative cancer...
PETACH TIKVA, Israel, Jan. 29, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming...
Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+...
Wilmington, DE, Jan. 29, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that...
Extended cash runway into late 2027, beyond a potentially registration-enabling azenosertib data readout from DENALI Part 2 Planned workforce reduction...
NEW YORK, Jan. 28, 2025 /PRNewswire/ -- Report with the AI impact on market trends - The global transmission electron microscope...